One versus two doses: What is the best use of vaccine in an influenza pandemic?
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R37 AI032042)
- National Institute of General Medical Sciences MIDAS (U01-GM070749, U54-GM111274)
- Swedish Research Council (2009-5759)
This publication has 20 references indexed in Scilit:
- Identification, Characterization, and Natural Selection of Mutations Driving Airborne Transmission of A/H5N1 VirusCell, 2014
- Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tractThe Lancet Respiratory Medicine, 2013
- Novel Avian-Origin Human Influenza A(H7N9) Can Be Transmitted Between Ferrets via Respiratory DropletsThe Journal of Infectious Diseases, 2013
- Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)JAMA, 2013
- Global Concerns Regarding Novel Influenza A (H7N9) Virus InfectionsNew England Journal of Medicine, 2013
- Critical immune and vaccination thresholds for determining multiple influenza epidemic wavesEpidemics, 2012
- Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects modelBMC Medical Research Methodology, 2010
- Containing Pandemic Influenza with Antiviral AgentsAmerican Journal of Epidemiology, 2004
- Study Designs for Evaluating Different Efficacy and Effectiveness Aspects of VaccinesAmerican Journal of Epidemiology, 1997
- Modeling malaria vaccines II: Population effects of stage-specific malaria vaccines dependent on natural boostingMathematical Biosciences, 1989